Antimicrobial Utilization among Neonates and Children: A Multicenter Point Prevalence Study from Leading Children's Hospitals in Punjab, Pakistan.

AWaRe classification Pakistan antibiotics children hospitals point prevalence survey

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
04 Aug 2022
Historique:
received: 22 06 2022
revised: 24 07 2022
accepted: 25 07 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Antimicrobial resistance (AMR) compromises global health due to the associated morbidity, mortality, and costs. The inappropriate use of antimicrobial agents is a prime driver of AMR. Consequently, it is imperative to gain a greater understanding of current utilization patterns especially in high-risk groups including neonates and children. A point prevalence survey (PPS) was conducted among three tertiary care children's hospitals in the Punjab province using the World Health Organization (WHO) methodology. Antibiotic use was documented according to the WHO AWaRe classification. Out of a total of 1576 neonates and children, 1506 were prescribed antibiotics on the day of the survey (prevalence = 95.5%), with an average of 1.9 antibiotics per patient. The majority of antibiotics were prescribed in the medical ward (75%), followed by surgical ward (12.8%). Furthermore, 56% of antibiotics were prescribed prophylactically, with most of the antibiotics (92.3%) administered via the parenteral route. The top three indications for antibiotics were respiratory tract infections (34.8%), gastrointestinal infections (15.8%), and prophylaxis for medical problems (14.3%). The three most common antibiotics prescribed were ceftriaxone (25.8%), amikacin (9.2%), and vancomycin (7.9%). Overall, 76.6% of the prescribed antibiotics were from Watch category followed by 21.6% from the Access group. There was a very high prevalence of antibiotic use among hospitalized neonates and children in this study. Urgent measures are needed to engage all the stakeholders to formulate effective ASPs in Pakistan, especially surrounding Watch antibiotics.

Identifiants

pubmed: 36009925
pii: antibiotics11081056
doi: 10.3390/antibiotics11081056
pmc: PMC9405424
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Antimicrob Chemother. 2016 Apr;71(4):1106-17
pubmed: 26747104
J Glob Antimicrob Resist. 2022 Jun;29:542-550
pubmed: 34915203
Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S47-55
pubmed: 26198369
Am J Infect Control. 2019 Apr;47(4):421-424
pubmed: 30471976
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93
pubmed: 34038294
Infect Dis (Lond). 2020 Jul;52(7):473-478
pubmed: 32314624
BMC Infect Dis. 2021 Mar 6;21(1):244
pubmed: 33676421
J Pharmacol Pharmacother. 2014 Apr;5(2):83-7
pubmed: 24799810
Pediatr Infect Dis J. 2021 Oct 1;40(10):899-905
pubmed: 34525004
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Pediatrics. 2018 Dec;142(6):
pubmed: 30459258
PLoS One. 2021 Jan 13;16(1):e0244866
pubmed: 33439876
Pak J Pharm Sci. 2017 Jul;30(4(Suppl.)):1483-1489
pubmed: 29044002
BMC Infect Dis. 2021 Dec 7;21(1):1231
pubmed: 34876041
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Sci Rep. 2021 Feb 11;11(1):3543
pubmed: 33574450
Springerplus. 2014 Dec 09;3:717
pubmed: 25674457
Expert Rev Anti Infect Ther. 2022 Jan;20(1):131-136
pubmed: 34047247
Int J Gen Med. 2021 Feb 18;14:515-530
pubmed: 33633461
Infect Control Hosp Epidemiol. 2019 Feb;40(2):248-249
pubmed: 30587255
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
Med J Aust. 2014 Dec 11;201(11):657-62
pubmed: 25495311
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S276-S284
pubmed: 33258934
BMC Infect Dis. 2019 Jul 22;19(1):650
pubmed: 31331272
Infect Prev Pract. 2021 Dec 11;4(1):100197
pubmed: 35005602
Antibiotics (Basel). 2022 Jan 14;11(1):
pubmed: 35052982
J Pediatr. 2018 Sep;200:210-217.e1
pubmed: 29784512
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
Expert Rev Anti Infect Ther. 2022 Jun;20(6):931-939
pubmed: 34591720
Expert Rev Anti Infect Ther. 2020 Sep;18(9):897-910
pubmed: 32394754
Antibiotics (Basel). 2017 Sep 13;6(3):
pubmed: 28902135
EClinicalMedicine. 2021 Jan 29;32:100727
pubmed: 33554094
Medicina (Kaunas). 2014;50(3):175-81
pubmed: 25323546
Lancet Infect Dis. 2019 Jan;19(1):67-75
pubmed: 30522834
Antimicrob Resist Infect Control. 2017 May 15;6:47
pubmed: 28515903
JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001
pubmed: 34222959
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):78-81
pubmed: 35120652
J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):970-974
pubmed: 34293148
J Pediatr. 2017 Mar;182:239-244.e1
pubmed: 28012694
World J Pediatr. 2018 Aug;14(4):335-343
pubmed: 30062648
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160
pubmed: 34225545
Front Pharmacol. 2021 Mar 29;12:601561
pubmed: 33854430
Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293
pubmed: 30755077
Lancet Infect Dis. 2018 Oct;18(10):1066-1067
pubmed: 30303099
Pathog Glob Health. 2021 Nov 16;:1-7
pubmed: 34783630
Euro Surveill. 2012 Nov 15;17(46):
pubmed: 23171822
Biomed Res Int. 2020 May 2;2020:6432580
pubmed: 32462008
Int J Infect Dis. 2010 Jan;14(1):e55-61
pubmed: 19487149

Auteurs

Zia Ul Mustafa (ZU)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.
Department of Pharmacy Services, District Headquarter (DHQ) Hospital, Pakpattan 57400, Pakistan.

Amer Hayat Khan (AH)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.

Muhammad Salman (M)

Department of Pharmacy, The University of Lahore, Lahore 54700, Pakistan.

Syed Azhar Syed Sulaiman (SA)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow G4 0RE, UK.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.

Classifications MeSH